New Delhi, Feb. 1 -- In a major push for innovation-driven healthcare manufacturing, Finance Minister Nirmala Sitharaman on Sunday announced Biopharma SHAKTI in the union Budget 2026-27, with a financial outlay of Rs 10,000 crore over five years.
The initiative aims to establish India as a global biopharma manufacturing hub amid rising demand for biologics and biosimilars.
Speaking during her budget speech, the Finance Minister explained that Biopharma SHAKTI, short for Strategy for Healthcare Advancement through Knowledge, Technology & Innovation, is designed to respond to India's changing disease profile, marked by a growing burden of non-communicable diseases such as diabetes, cancer, and autoimmune disorders.
"Biologic medicines are ...